Waters Corp. stock price target lowered to $373 at TD Cowen
#Waters Corporation #TD Cowen #Price Target #Stock Rating #Life Sciences Tools #Analytical Instruments #Equity Research
📌 Key Takeaways
- TD Cowen reduced the price target for Waters Corp. (WAT) from $398 to $373.
- The investment firm maintained its 'Hold' rating on the life sciences technology stock.
- The adjustment is attributed to evolving market conditions and cautious spending in the pharmaceutical sector.
- Waters Corporation specializes in analytical instruments like liquid chromatography and mass spectrometry.
📖 Full Retelling
Financial analysts at TD Cowen lowered their price target for Waters Corporation stock from $398 to $373 on Monday, October 28, following a revised assessment of the company’s near-term growth prospects in the global laboratory technology market. The adjustment comes as the investment firm maintains a 'Hold' rating on the Milford, Massachusetts-based life sciences company, signaling a cautious approach toward the stock’s performance in the coming quarters. Analysts cited shifting demand cycles and broader economic pressures within the pharmaceutical and industrial sectors as the primary drivers behind the valuation update.
Waters Corporation, a major player in the analytical instrument industry, has been navigating a complex recovery period as its primary customers—ranging from academic institutions to large-scale pharmaceutical firms—adjust their capital expenditure budgets. The downward revision by TD Cowen reflects concerns that the recovery in high-end liquid chromatography and mass spectrometry sales may be more gradual than previously anticipated. Despite the price target cut, the firm’s decision to maintain a 'Hold' rating suggests that while the stock faces immediate headwinds, its underlying business model remains stable in a competitive niche.
Industry observers are closely watching how Waters Corporation manages its research and development investments and operational costs amidst this period of market volatility. The reduction to $373 per share aligns the firm’s expectations more closely with current trading multiples in the life sciences tools sector. As the company prepares to share its latest financial results, investors are looking for clarity on whether the slowed demand is a temporary regional issue or a more systemic shift in the global laboratory equipment lifecycle.
🏷️ Themes
Finance, Stock Market, Life Sciences
📚 Related People & Topics
TD Cowen
American investment bank
TD Cowen (formerly Cowen Inc.), is an American multinational investment bank and financial services division of TD Securities that operates through two business segments: a broker-dealer and an investment management division. The company's broker-dealer division offers investment banking services, ...
Waters Corporation
American instrument company
Waters Corporation, headquartered in Milford, Massachusetts, provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life, materials and food sciences industries. The company has primary manufacturing facilities in 9 U.S. ...
🔗 Entity Intersection Graph
Connections for TD Cowen:
- 🌐 Computer security (1 shared articles)
- 🏢 Fortinet (1 shared articles)
- 🌐 Roblox (1 shared articles)
📄 Original Source Content
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry As Claude disrupts stock market, Anthropic researcher warns ’world is in peril’ Gold, silver prices rise amid U.S.-Iran tensions, blowout January payrolls data Dow halts three-day win streak as blowout jobs data curbs rate cut bets Citi pushes back Fed rate cuts to May after blowout January jobs report (South Africa Philippines Nigeria) Waters Corp. stock price target lowered to $373 at TD Cowen Analyst Ratings Published 02/10/2026, 07:48 AM Waters Corp. stock price target lowered to $373 at TD Cowen 0 WAT 0.69% BDX 5.21% Investing.com - TD Cowen has reduced its price target on Waters Corp. (NYSE:WAT) to $373.00 from $400.00 while maintaining a Hold rating on the stock. This target remains above the current price of $328.14, though below the analyst high target of $480. The price target adjustment follows Waters Corp.’s 14% stock decline after its fourth-quarter earnings report, which coincided with Becton Dickinson’s weak calendar fourth quarter performance that saw a 10.5% decline at constant currency. InvestingPro data confirms the stock has taken a significant hit, falling 13.41% in the past week alone, with the RSI now suggesting the stock is in oversold territory. According to TD Cowen, Waters management remains "highly confident" in its deal with BDX and the growth and synergy opportunities ahead, attributing the weak fourth quarter to "one-off factors." The research firm noted that Waters’ fourth-quarter core organic growth was in line with expectations, marking the first time in over a year that the company did not beat estimates. TD Cowen indicated that Waters’ valuation appears "more attractive" following the recent pullback, but emphasized that gaining confidence in the assumed BDX recovery will be key for the stock’s performance. In other recent news, Waters Corporation reported its fourth-quarter 2025 earnings, slightly surpassing expectations. The company posted an adjusted earnings per share o...